Engineering route for complex organics, solvents, apis, toxicity and batch-to-batch variation. Final configuration is based on representative sampling, treatability evidence and the agreed discharge or reuse target.
Campaign Loads, Solvents and Biological Inhibition
| Design item | Unit / reference | Engineering basis |
|---|---|---|
| Hydraulic and production schedule | m³/hour; m³/day; batch timing | Describe each production campaign, mother liquor, cleaning release and utility stream. Give normal, maximum and batch flow together with solvent and organic mass loads. |
| Feed analysis | Laboratory units and named test methods | Product/campaign inventory, COD/TOC, BOD5, solvents, salts, relevant active ingredients, toxicity/inhibition, pH, nitrogen and AOX where applicable. |
| Campaign discharge | m³/batch; batch frequency; kg COD/batch | Use the worst credible campaign and cleaning sequence in equalization and containment design. |
| Solvents and volatility | Individual solvents mg/L; VOC and flash-point data | Evaluate recovery, closed handling, ventilation and treatment compatibility. |
| Biological inhibition | Respirometry; inhibition %; biodegradability | Test treatment-feed blends rather than assuming all measured COD is biodegradable. |
| Persistent compounds | Relevant APIs/intermediates; AOX; toxicity | Select oxidation, adsorption or separation from identified contaminants and treatability tests. |
| Salt and residue | TDS, chloride/sulfate; sludge and concentrate | Identify regeneration and concentrate outlets before selecting a reuse process. |
Capacity calculation and design boundary
Worked campaign-load example: 60 m³/day at 10,000 mg/L COD carries 600 kg COD/day. A short concentrated release may control equalization sizing even when daily flow is small.
Outlet and acceptance schedule
The selected IFC values below refer to pharmaceutical and biotechnology manufacturing. Chemical projects require the guideline and discharge permit appropriate to the actual products and contaminants.
Selected IFC industry guideline references for direct surface-water discharge are listed for comparison. Local permits, receiving-water conditions and the full source guideline define applicability and the agreed project acceptance basis.
| Parameter | IFC guideline reference |
|---|---|
| pH | 6–9 |
| BOD5 | 30 mg/L |
| COD | 150 mg/L |
| TSS | 10 mg/L |
| Oil and grease | 10 mg/L |
| AOX | 1 mg/L |
Engineering reference: IFC EHS Guidelines for Pharmaceuticals and Biotechnology Manufacturing (2007), Table 2.
What It Is / Wastewater Characteristics
Complex organics, solvents, APIs, toxicity and batch-to-batch variation. The design basis must describe normal, peak and upset conditions rather than a single grab sample.
Typical Sources and Applications
Relevant process drains, production washwater, utility blowdown and segregated side streams are mapped at source before combining treatment duties.
Required Influent Data and Sampling Basis
Provide hourly and daily flow, peaks, pH, temperature, COD/TOC and biodegradability, suspended solids, conductivity/TDS, priority pollutants, toxicity indicators, production cycles and current chemical use. Composite and event samples should cover normal and upset operation.
Process Selection Logic
Selection begins with source segregation and treatability tests, then balances biological, physicochemical, membrane and thermal boundaries against residue outlets and acceptance requirements.
Wastewater-Specific Process Flow
- 1. Source mapping
- 2. Solvent / toxicity control
- 3. Equalization
- 4. Physicochemical treatment
- 5. Biological treatment
- 6. Oxidation / carbon polishing
System and Equipment Architecture
Main equipment: Segregated tanks, solvent recovery interface, reaction systems, biological reactors, ozone/Fenton and activated carbon.
Residues, Utilities and Environmental Interfaces
Solvent-bearing streams, off-gas, toxic sludge and spent carbon are segregated and documented.
Power, air, water, thermal utilities, chemical storage and consumption are calculated from the agreed flow and quality envelope. Off-gas, odor and ventilation controls are incorporated where the selected process requires them.
Monitoring and Operating Records
Record campaign identity, transfer volume, pH, temperature and conductivity; use organic-load and toxicity testing to define release to biological treatment.
CAPEX / OPEX Drivers
Major drivers include contaminant load and variability, materials of construction, footprint, redundancy, chemical and energy duties, sludge/concentrate outlet, automation level and the required discharge or reuse quality.
Customer Engineering Inputs and Acceptance
Customer inputs include verified analyses, process inventory, site layout, utility conditions, hazardous-area requirements, local codes and the acceptance sampling protocol. Outputs are agreed as treated water, recovered materials and managed residues at defined battery limits.
Related capabilities: Turnkey process plants, factory modernization, residue recovery, renewable energy and SMART monitoring.
Frequently Asked Questions
Which feed analyses are needed for chemical and pharmaceutical wastewater?
Product/campaign inventory, COD/TOC, BOD5, solvents, salts, relevant active ingredients, toxicity/inhibition, pH, nitrogen and AOX where applicable.
How is chemical and pharmaceutical wastewater treatment capacity sized?
Describe each production campaign, mother liquor, cleaning release and utility stream. Give normal, maximum and batch flow together with solvent and organic mass loads.
Why should mother liquor be assessed separately from washing water?
A small mother-liquor volume can carry a large solvent, salt or persistent-organic load. Recovery or dedicated pretreatment may be more suitable than dilution into the main biological feed.
Does a low COD result prove that active ingredients are controlled?
No. COD is an aggregate measure. Relevant active ingredients, intermediates and toxicity endpoints require their own analytical and acceptance basis.
What residues must a chemical and pharmaceutical wastewater project handle?
Include solvent recovery residues, hazardous sludge, spent carbon, membrane concentrates and air-treatment media, with compatible storage and approved outlets.
Which operating records matter for chemical and pharmaceutical wastewater?
Record campaign identity, transfer volume, pH, temperature and conductivity; use organic-load and toxicity testing to define release to biological treatment.
How does the worked sizing example for chemical and pharmaceutical wastewater apply?
Worked campaign-load example: 60 m³/day at 10,000 mg/L COD carries 600 kg COD/day. A short concentrated release may control equalization sizing even when daily flow is small.
What outlet quality must be agreed for chemical and pharmaceutical wastewater?
The selected IFC values below refer to pharmaceutical and biotechnology manufacturing. Chemical projects require the guideline and discharge permit appropriate to the actual products and contaminants.